title: [Therapeutic of respiratory manifestations at the early phase of acute myeloid leukaemia].
abstract: The effective management of the respiratory manifestations at the early phase of acute myeloid hemopathies, especially acute myeloid leukaemia, frequently requires a close collaboration between hematologists, pulmonologists and intensivists. Dominated by infectious etiologies, there are however "specific" disease entities that should not be neglected in the diagnostic and therapeutic approach. These include lung leukostasis, leukemic lung infiltration, the cell lysis pneumopathy and the secondary alveolar proteinosis. These were the subject of a review in the Revue des Maladies Respiratoires published in 2010. We wished to review the management of these clinical situations, the severity of which mean patients frequently require intensive care unit admission. We are only able to make proposals for management here as there is little consensus, except in the metabolic care of tumour lysis syndrome. These data must therefore be reinterpreted regularly as new publications become available.
authors: Réanimation médico-chirurgicale, hôpital Avicenne, 125, rue de Stalingrad, 93009 Bobigny, France. francois.vincent@avc.aphp.fr
authors: F
authors: F
authors: Vincent
authors: M-A
authors: MA
authors: Hospital
authors: V
authors: V
authors: Lemiale
authors: F
authors: F
authors: Bruneel
authors: M
authors: M
authors: Darmon
authors: F
authors: F
authors: Gonzalez
authors: A
authors: A
authors: Kouatchet
authors: D
authors: D
authors: Mokart
authors: F
authors: F
authors: Pène
authors: A
authors: A
authors: Rabbat
authors: Y
authors: Y
authors: Cohen
authors: E
authors: E
authors: Azoulay
mesh_terms: D006760:Hospitalization; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000628:therapy*; D017254:Leukemic Infiltration / Q000473:pathology*; D018921:Leukostasis / Q000473:pathology*; D008168:Lung / Q000473:pathology*; D008171:Lung Diseases / Q000473:pathology*; D010956:Plasmapheresis